CheckMate 204: ' Practice-Changing ' for Metastatic Melanoma CheckMate 204: ' Practice-Changing ' for Metastatic Melanoma

The ipilimumab plus nivolumab combination gives patients a reasonable chance of CNS tumor regression, thus not requiring radiation, according to Jeffrey Weber.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news